Sequent Scientific Limited has informed the Exchange about Copy of Newspaper Publication
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sequent Scientific Limited has submitted copies of newspaper advertisements published on July 29, 2025 in Business Standard (English) and Nava Telangana (Telugu) to BSE and NSE. These ads notify equity shareholders and unsecured trade creditors about meetings to be held as per an NCLT Hyderabad Bench-II order dated July 23, 2025. The meetings are part of a composite scheme of amalgamation involving Sequent Scientific, Symed Labs, Vandana Life Sciences, Appcure Labs, Vindhya Pharma, S.V. Labs, Vindhya Organics, Viyash Life Sciences, Geninn Life Sciences, and Sequent Research. This is a procedural compliance filing under SEBI Listing Regulations, with the actual newspaper page also containing unrelated JM Financial Home Loans possession notices.
This is a routine regulatory disclosure confirming that NCLT-directed shareholder and creditor meetings for the proposed multi-entity amalgamation have been formally notified via newspaper publication. No direct price action is expected, but the filing keeps shareholders informed of the next steps in the merger process, which involves 10 companies in the life sciences/pharma space.